Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation.

MLA

Knight, Jennifer M., et al. “Repurposing Existing Medications as Cancer Therapy: Design and Feasibility of a Randomized Pilot Investigating Propranolol Administration in Patients Receiving Hematopoietic Cell Transplantation.” BMC Cancer, vol. 18, no. 1, May 2018, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12885-018-4509-0.

APA

Knight, J. M., Kerswill, S. A., Hari, P., Cole, S. W., Logan, B. R., D’Souza, A., Shah, N. N., Horowitz, M. M., Stolley, M. R., Sloan, E. K., Giles, K. E., Costanzo, E. S., Hamadani, M., Chhabra, S., Dhakal, B., & Rizzo, J. D. (2018). Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. BMC Cancer, 18(1), 1–12. https://doi.org/10.1186/s12885-018-4509-0

Chicago

Knight, Jennifer M., Stephanie A. Kerswill, Parameswaran Hari, Steve W. Cole, Brent R. Logan, Anita D’Souza, Nirav N. Shah, et al. 2018. “Repurposing Existing Medications as Cancer Therapy: Design and Feasibility of a Randomized Pilot Investigating Propranolol Administration in Patients Receiving Hematopoietic Cell Transplantation.” BMC Cancer 18 (1): 1–12. doi:10.1186/s12885-018-4509-0.